Skip to main content
SpringerLink
Log in

Statins and CVD prevention in the diabetic population: Implications of the CARDS trial

  • Clinical Trials Report
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–234.

    Article  CAS  PubMed  Google Scholar 

  2. McFarlane SI, Muniyappa R, Francisco R, Sowers JR: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab 2002, 87:1451–1458.

    Article  CAS  PubMed  Google Scholar 

  3. Ehrenstein MR, Jury EC, Mauri C: Statins for atherosclerosis as good as it gets? N Engl J Med 2005, 352:73–75.

    Article  CAS  PubMed  Google Scholar 

  4. Collins R, Armitage J, Parish S, et al.: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet 2003, 361:2005–2016.

    Article  PubMed  Google Scholar 

  5. Sever PS, Dahlof B, Poulter NR, et al.: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial — Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 2003, 361:1149–1158.

    Article  CAS  PubMed  Google Scholar 

  6. Garg A: Statins for all patients with type 2 diabetes: not so soon. Lancet 2004, 364:641–642.

    Article  PubMed  Google Scholar 

  7. Colhoun HM, Betteridge JD, Durrington PN, et al.: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial. Lancet 2004, 364:685–696.

    Article  CAS  PubMed  Google Scholar 

  8. McFarlane SI, Shin JJ, Rundek T, Bigger T: Prevention of type 2 diabetes. Curr Diab Rep 2003, 3:235–241.

    PubMed  Google Scholar 

  9. Voelker R: Widespread statin use recommended for patients with type 2 diabetes. JAMA 2004, 291:2419–2420.

    Article  CAS  PubMed  Google Scholar 

  10. Grundy SM, Cleeman JI, Bairey Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004, 110:227–239.

    Article  PubMed  Google Scholar 

  11. Sinzinger H, Wolfram R, Peskar BA: Muscular side effects of statins. J Cardiovasc Pharmacol 2002, 40:163–171.

    Article  CAS  PubMed  Google Scholar 

  12. Muldoon MF, Barger SD, Ryan CM, et al.: Effects of lovastatin on cognitive function and psychological well-being. Am J Med 2000, 108:538–546.

    Article  CAS  PubMed  Google Scholar 

  13. Topol EJ: Intensive statin therapy-a sea change in cardiovascular prevention. N Engl J Med 2004, 350:1562–1564.

    Article  CAS  PubMed  Google Scholar 

  14. Brandle M, Davidson MB, Schriger DL, et al.: Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care 2003, 26:1796–1801.

    Article  CAS  PubMed  Google Scholar 

  15. Pimpinella G, Malgarini RB, Martini N: Statins for patients with type 2 diabetes. Lancet 2004, 364:1933–1934.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Omar Murad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Palmer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Sowers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samy I. McFarlane MD,MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murad, O., Palmer, J., Sowers, J. et al. Statins and CVD prevention in the diabetic population: Implications of the CARDS trial. Curr Diab Rep 5, 191–193 (2005). https://doi.org/10.1007/s11892-005-0008-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0008-1

Keywords

Search

Navigation